CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
Phase 2 study to assess efficacy and safety of once daily linperlisib in patients with advanced peripheral T/NK cell lymphoma
Company appoints five new independent directors to reconstituted board
AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
Subscribe To Our Newsletter & Stay Updated
